Insider sale
WEREWOLF THERAPEUTICS, INC.
$47.5K
69.90K shares
What this filing means
UBS ONCOLOGY IMPACT FUND L.P. plans to sell 69.90K shares of WEREWOLF THERAPEUTICS, INC. valued at approximately $47.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2026ACC: 0001628280-26-033567
10% Owner
Since Apr 2021
69.90K
Shares to sell
$47.5K
Approx. market value
69.90K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
5/4/2021
69.90KTotal acquired69.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2021 | Private Placement Cash | 69.90K | — |
| Total | 69.90K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
69.90K
Market value
$47.5K
5/11/2026
Total
Units
69.90K
Value
$47.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/11/2026 | 69.90K | $47.5K | NASDAQ | Planned |
| Total | 69.90K | $47.5K | ||